Hydrogel wound dressing with slow-release effect and preparation method thereof
By charring the northern bean roots at high temperature, ultrasonic enzymatic treatment and drying, combined with chitosan quaternary ammonium salt, the problem of drug release in hydrogel wound dressings was solved, and the significant sustained release effect was achieved and improve antibacterial performance, suitable for the treatment of various wounds.
Patent Information
- Application Number
- CN202411258351.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing hydrogel wound dressings have poor sustained release performance when loading drugs, and the drug is released too quickly.
By high-temperature charring, ultrasonic enzymatic treatment and drying of the northern bean root, the modified northern bean root is obtained as a wall material, and combined with chitosan quaternary ammonium salt to form sustained-release particles, and the antibacterial drug is loaded inside the wall material. , prolong drug release time and enhance the antibacterial properties of the dressing.
It significantly extends the drug release time, improves the sustained release performance of hydrogel wound dressings, and enhances its antibacterial properties, and is suitable for the treatment of multiple wounds.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedical materials, and in particular relates to a hydrogel wound dressing with sustained-release efficacy and a preparation method thereof. Background Art
[0002] Wound dressings are medical materials used to cover and protect wounds. They can help keep wounds moist, promote healing, and prevent infection. Wound dressings mainly include traditional dressings such as gauze and synthetic fibers, hydrocolloid dressings, hydrogel dressings, alginate dressings, foam dressings, silver ion dressings, etc. In actual use, the size, depth, amount of exudate, whether there is necrotic tissue, and individual differences of the patient should be considered to select the appropriate dressing.
[0003] The hydrogel has a smooth surface, good biocompatibility, and strong water absorption capacity. It can undergo repeated hydration when in contact with tissues, absorbing moisture from the tissues into the dressing, and can continuously absorb exudates from the wound surface, and then form a gel, which will not stick when replaced. The hydrogel dressing can adhere tightly to the uneven wound surface, reduce the chance of bacterial growth, prevent wound infection, accelerate angiogenesis, and promote epithelial cell growth. Hydrogel dressings are suitable for a variety of wounds, including superficial burns, partial-thickness burns, donor site wounds, postoperative wounds, and skin abrasions. It is also particularly suitable for the treatment of chronic wounds such as pressure sores and venous ulcers. It can promote the proliferation of microvessels and the formation of granulation tissue, and accelerate wound healing.
[0004] At present, antibacterial drugs are often loaded into hydrogel wound dressings to achieve sustained release of drugs and prevent wound infection. However, existing hydrogel wound dressings have problems such as poor sustained release performance and too fast drug release when loaded with drugs. Summary of the invention
[0005] The purpose of the present invention is to provide a hydrogel wound dressing with sustained release efficacy and a preparation method thereof, so as to solve the problems of poor sustained release performance and too fast release of drugs in existing hydrogel wound dressings when loaded with drugs.
[0006] In the first aspect, the present invention provides a hydrogel wound dressing with sustained-release efficacy, which includes a hydrogel and sustained-release particles loaded inside the hydrogel, the sustained-release particles including a wall material and a core material loaded inside the wall material; wherein the wall material includes modified northern bean root and chitosan quaternary ammonium salt, and the modified northern bean root is obtained by sequentially subjecting the northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying.
[0007] In the present invention, the inventors have found that after the core material is loaded inside the wall material, the release time of the core material is greatly prolonged, so that the core material (antibacterial drug) can be slowly released. Among them, after the northern bean root is first subjected to high-temperature carbonization treatment, a small molecule material rich in hydroxyl and carboxyl groups can be obtained, and the pores of the carbonized material are well developed. The carbonized material is further treated with ultrasonic enzymatic hydrolysis to further degrade the material to obtain a small molecule material with increased hydroxyl and carboxyl groups. When the wall material is obtained with modified northern bean root and chitosan quaternary ammonium salt as components, because the modified northern bean root is rich in hydroxyl and carboxyl groups and has a well-developed pore structure, under the action of electrostatics, the chitosan quaternary ammonium salt is adsorbed into part of the pores of the modified northern bean root. After the two are combined, the release of the core material can be significantly delayed. In addition, chitosan quaternary ammonium salt has antibacterial properties, and therefore, the antibacterial properties of the hydrogel wound dressing can be further enhanced.
[0008] In some embodiments, the mass ratio of sustained-release particles to hydrogel is 1:(5-9), for example, it can be 1:5, 1:6, 1:7, 1:8, 1:9 or other ratios within this range; the mass ratio of core material to wall material is 1:(7-10), for example, it can be 1:7, 1:8, 1:9, 1:10 or other ratios within this range; the mass ratio of modified northern bean root and chitosan quaternary ammonium salt is (6-11):(1-3), for example, it can be 6:1, 6:2, 6:3, 9:1, 9:2, 9:3, 11:1, 11:2, 11:3 or other ratios within this range.
[0009] In some embodiments, in the preparation process of modified northern bean root, the high-temperature carbonization step specifically includes: placing the northern bean root in a vacuum environment, and carbonizing it at a temperature of 250~450℃ (for example, it can be 250℃, 300℃, 350℃, 400℃, 450℃ or other values within the range) for 2~4h, for example, it can be 2h, 2.5h, 3h, 3.5h, 4h or other values within the range.
[0010] In the present invention, the inventors further studied and found that by controlling the temperature and time of high-temperature carbonization within a specific range, a material with well-developed pores and rich in hydroxyl and carboxyl groups can be obtained.
[0011] In some embodiments, during the preparation of the modified northern bean root, the ultrasonic enzymatic hydrolysis step specifically includes: dissolving the product of high-temperature carbonization of the northern bean root in water, then adding plant hydrolases, and performing enzymatic hydrolysis under ultrasonic conditions; wherein the amount of plant hydrolases added is 0.1-0.2%, for example, it can be 0.1%, 0.12%, 0.14%, 0.16%, 0.18%, 0.2% or other values within this range; the ultrasonic conditions include: an interval of 20-30s, for example, it can be The invention relates to an enzymatic reaction of at least one embodiment of the present invention, wherein the enzymatic reaction is performed at a temperature of 25 to 35°C, for example, 25°C, 27°C, 30°C, 33°C, 35°C or other values within the range. The enzymatic reaction is performed at a temperature of 25 to 35°C, for example, 25°C, 27°C, 30°C, 33°C, 35°C or other values within the range.
[0012] In the present invention, the inventors further discovered that adding ultrasound during the hydrolysis process can improve the reaction efficiency and make the reaction more thorough.
[0013] In some embodiments, in the preparation process of the modified northern bean root, the drying step specifically includes: drying the product after ultrasonic enzymatic hydrolysis at a temperature of 80~100℃ (for example, 80℃, 85℃, 90℃, 95℃, 100℃ or other values within the range) for 1~2h, for example, 1h, 1.5h, 2h or other values within the range.
[0014] In some embodiments, the hydrogel includes polyvinyl alcohol and tannic acid, and the mass ratio of polyvinyl alcohol to tannic acid is 1:(0.1-0.3), for example, it can be 1:0.1, 1:0.15, 1:0.2, 1:0.25, 1:0.3 or other ratios within this range.
[0015] In some embodiments, the core material includes an antibacterial drug, and the antibacterial drug is selected from at least one of levofloxacin, aspirin and indomethacin.
[0016] In the present invention, the antibacterial drug can be selected from conventional drugs in the prior art according to actual use needs, and is preferably at least one of levofloxacin, aspirin and indomethacin.
[0017] In a second aspect, the present invention provides a method for preparing a hydrogel wound dressing with sustained-release efficacy as described above, comprising the following steps: dissolving modified northern bean root and chitosan quaternary ammonium salt in water to obtain a wall material solution; dissolving an antibacterial drug in an organic solvent to obtain a core material solution; adding the core material solution dropwise to the wall material solution, mixing evenly, and obtaining sustained-release particles after high-pressure homogenization and freeze-drying; dissolving polyvinyl alcohol and tannic acid in water to obtain a mixed solution, adding sustained-release particles to the mixed solution, and obtaining a hydrogel wound dressing after freezing-thawing.
[0018] In the present invention, the raw materials are cheap and easily available, the preparation method of the hydrogel wound dressing is simple, and the raw materials used have good biocompatibility and low toxicity, so it is convenient for large-scale promotion and application.
[0019] In some embodiments, in the preparation process of sustained-release particles, the high-pressure homogenization step specifically includes: at a temperature of 30-35°C (for example, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C or other values within the range) and a pressure of 150-180par (for example, 150par, 160par, 170par, 180par or other values within the range), homogenizing 4 to 6 times, for example, 4 times, 5 times, 6 times or other values within the range; the freeze-drying step specifically includes: at a temperature of -15-0°C (for example, -15°C, -10°C, -5°C, 0°C or other values within the range), drying for 4 to 6 hours, for example, 4 hours, 5 hours, 6 hours or other values within the range.
[0020] In some embodiments, during the preparation of the hydrogel wound dressing, the freezing-thawing step specifically includes: first freezing for 15 to 30 hours, for example, 15 hours, 20 hours, 25 hours, 30 hours or other values within the range, at a temperature of -40 to -10°C (for example, -40°C, -30°C, -20°C, -10°C or other values within the range); then thawing for 1 to 10 hours, for example, 1 hour, 3 hours, 5 hours, 7 hours, 10 hours or other values within the range, at a temperature of 10 to 20°C (for example, 10°C, 12°C, 14°C, 16°C, 18°C, 20°C or other values within the range).
[0021] The beneficial effects of the present invention are as follows: different from the prior art, the present invention sequentially performs high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying on the northern bean root to obtain a modified northern bean root, then uses the modified northern bean root and chitosan quaternary ammonium salt as components of the wall material, loads the core material inside the wall material, and obtains sustained-release particles; finally, the sustained-release particles are loaded inside the hydrogel to obtain a hydrogel wound dressing with a strong sustained-release effect; in addition, since the chitosan quaternary ammonium salt has antibacterial properties, the hydrogel wound dressing also has certain antibacterial properties. DETAILED DESCRIPTION
[0022] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0023] The experimental methods without specific conditions in the examples are usually carried out according to conventional conditions and conditions described in the manual, or according to conditions recommended by the manufacturer. The general equipment, materials, reagents, etc. used are all available from commercial channels unless otherwise specified.
[0024] Example 1 A hydrogel wound dressing with sustained-release efficacy comprises a hydrogel and sustained-release particles loaded inside the hydrogel, the mass ratio of the sustained-release particles to the hydrogel is 1:7, the hydrogel comprises polyvinyl alcohol and tannic acid, and the mass ratio of the polyvinyl alcohol to the tannic acid is 1:0.2; the sustained-release particles comprise a wall material and levofloxacin loaded inside the wall material, the mass ratio of the levofloxacin to the wall material is 1:9; wherein the wall material comprises modified northern bean root and chitosan quaternary ammonium salt, the mass ratio of the modified northern bean root to the chitosan quaternary ammonium salt is 8:2; the modified northern bean root is obtained by sequentially subjecting the northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying.
[0025] The preparation method of the modified northern bean root comprises the following steps: 1) Place the root of Sophora flavescens in a vacuum environment and carbonize it at 300°C for 3 hours; 2) dissolving the carbonized product obtained in step 1) in water, then adding 0.15wt% plant hydrolase, and performing enzymatic hydrolysis under ultrasonic conditions, wherein the ultrasonic conditions include: interval of 25s, power of 60W; enzymatic hydrolysis reaction time of 1h, temperature of 30°C; 3) Drying the product obtained after ultrasonic enzymatic hydrolysis in step 2) at 90° C. for 1.5 h to obtain modified northern bean root.
[0026] The preparation method of the hydrogel wound dressing comprises the following steps: S1, dissolving modified Radix Glechomae var. vulgaris and chitosan quaternary ammonium salt in water to obtain a wall material solution; dissolving levofloxacin in an organic solvent to obtain a levofloxacin solution; S2, adding the levofloxacin solution dropwise to the wall material solution, mixing evenly, homogenizing 5 times at a temperature of 33°C and a pressure of 170par, and drying the obtained product at a temperature of -5°C for 5 hours to obtain sustained-release particles; S3. Dissolve polyvinyl alcohol and tannic acid in water to obtain a mixed solution, add the sustained-release particles obtained in step S2 to the mixed solution, first freeze it at a temperature of -25°C for 20 hours, and then thaw it at a temperature of 15°C for 5 hours to obtain a hydrogel wound dressing.
[0027] Example 2 A hydrogel wound dressing with sustained-release efficacy comprises a hydrogel and sustained-release particles loaded inside the hydrogel, the mass ratio of the sustained-release particles to the hydrogel is 1:5, the hydrogel comprises polyvinyl alcohol and tannic acid, and the mass ratio of the polyvinyl alcohol to the tannic acid is 1:0.1; the sustained-release particles comprise a wall material and levofloxacin loaded inside the wall material, the mass ratio of the levofloxacin to the wall material is 1:7; wherein the wall material comprises modified northern bean root and chitosan quaternary ammonium salt, the mass ratio of the modified northern bean root to the chitosan quaternary ammonium salt is 6:1; the modified northern bean root is obtained by sequentially subjecting the northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying.
[0028] The preparation method of the modified northern bean root comprises the following steps: 1) Place the roots of Sophora flavescens in a vacuum environment and carbonize them at 250°C for 4 hours; 2) dissolving the carbonized product obtained in step 1) in water, then adding 0.1wt% plant hydrolase, and performing enzymatic hydrolysis under ultrasonic conditions, wherein the ultrasonic conditions include: interval of 20s, power of 70W; enzymatic hydrolysis reaction time of 1.5h, temperature of 35°C; 3) Drying the product obtained after ultrasonic enzymatic hydrolysis in step 2) at 80° C. for 2 h to obtain modified northern bean root.
[0029] The preparation method of the hydrogel wound dressing comprises the following steps: S1, dissolving modified Radix Glechomae var. vulgaris and chitosan quaternary ammonium salt in water to obtain a wall material solution; dissolving levofloxacin in an organic solvent to obtain a levofloxacin solution; S2, adding the levofloxacin solution dropwise to the wall material solution, mixing evenly, homogenizing 6 times at a temperature of 30°C and a pressure of 180par, and drying the obtained product at a temperature of -15°C for 6 hours to obtain sustained-release particles; S3. Dissolve polyvinyl alcohol and tannic acid in water to obtain a mixed solution, add the sustained-release particles obtained in step S2 to the mixed solution, first freeze it at a temperature of -40°C for 30 hours, and then thaw it at a temperature of 10°C for 10 hours to obtain a hydrogel wound dressing.
[0030] Example 3 A hydrogel wound dressing with sustained-release efficacy comprises a hydrogel and sustained-release particles loaded inside the hydrogel, the mass ratio of the sustained-release particles to the hydrogel is 1:9, the hydrogel comprises polyvinyl alcohol and tannic acid, and the mass ratio of the polyvinyl alcohol to the tannic acid is 1:0.3; the sustained-release particles comprise a wall material and levofloxacin loaded inside the wall material, the mass ratio of the levofloxacin to the wall material is 1:10; wherein the wall material comprises modified northern bean root and chitosan quaternary ammonium salt, the mass ratio of the modified northern bean root to the chitosan quaternary ammonium salt is 11:3; the modified northern bean root is obtained by sequentially subjecting the northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying.
[0031] The preparation method of the modified northern bean root comprises the following steps: 1) Place the root of Sophora flavescens in a vacuum environment and carbonize it at 450°C for 2 hours; 2) dissolving the carbonized product obtained in step 1) in water, then adding 0.2wt% plant hydrolase, and performing enzymatic hydrolysis under ultrasonic conditions, wherein the ultrasonic conditions include: interval of 30s, power of 50W; enzymatic hydrolysis reaction time of 0.5h, temperature of 25°C; 3) Drying the product obtained after ultrasonic enzymatic hydrolysis in step 2) at 100° C. for 1 h to obtain modified northern bean root.
[0032] The preparation method of the hydrogel wound dressing comprises the following steps: S1, dissolving modified Radix Glechomae var. vulgaris and chitosan quaternary ammonium salt in water to obtain a wall material solution; dissolving levofloxacin in an organic solvent to obtain a levofloxacin solution; S2. Add the levofloxacin solution dropwise to the wall material solution, mix well, and then homogenize 4 times at a temperature of 35° C. and a pressure of 150 par. Dry the obtained product at a temperature of 0° C. for 4 hours to obtain sustained-release particles. S3. Dissolve polyvinyl alcohol and tannic acid in water to obtain a mixed solution, add the sustained-release particles obtained in step S2 to the mixed solution, first freeze it at a temperature of -10°C for 15 hours, and then thaw it at a temperature of 20°C for 1 hour to obtain a hydrogel wound dressing.
[0033] Comparative Example 1 The hydrogel wound dressing and the preparation method thereof in this comparative example are basically the same as those in Example 1, except that, during the preparation process of the modified northern bean root, the northern bean root is not subjected to high-temperature carbonization treatment.
[0034] Comparative Example 2 The hydrogel wound dressing and the preparation method thereof in this comparative example are basically the same as those in Example 1, except that, in the preparation process of the modified northern bean root, the northern bean root is not subjected to ultrasonic enzymatic hydrolysis treatment.
[0035] Comparative Example 3 The hydrogel wound dressing and the preparation method thereof in this comparative example are basically the same as those in Example 1, except that, during the preparation of the hydrogel wound dressing, chitosan quaternary ammonium salt is not added to the wall material.
[0036] Comparative Example 4 The hydrogel wound dressing and the preparation method thereof in this comparative example are basically the same as those in Example 1, except that, in the preparation process of the hydrogel wound dressing, no modified Rhizoma Coptidis was added to the wall material.
[0037] Performance Testing 1 g of the hydrogel wound dressings prepared in Examples 1-3 and Comparative Examples 1-4 were respectively taken into glass bottles, 100 mL of phosphate buffer solution (0.01 mol / L, pH 7.2) was added, and constant temperature oscillation was performed at a temperature of 37° C. and a rotation speed of 100 rpm. 2 mL of sample was measured at preset time points (5, 10, 24, 48, 72, 96, 120), and 2 mL of freshly prepared phosphate buffer was added at the same time. The content of levofloxacin in the sample was detected according to the method in the pharmacopoeia, so as to obtain the cumulative release rate of levofloxacin at different time points. The results are shown in Table 1 below.
[0038] Table 1 Cumulative release rate of levofloxacin in hydrogel wound dressings
[0039] It can be seen from the data in Table 1 that the hydrogel wound dressings prepared in Examples 1-3 of the present invention have good drug sustained-release properties.
[0040] In Comparative Examples 1 and 2, the northern bean root was not subjected to high-temperature carbonization treatment or ultrasonic enzymatic hydrolysis treatment. The results showed that the drug sustained-release performance of the prepared hydrogel wound dressing decreased to a certain extent. This result further shows that the sustained-release performance of the material can be significantly improved after the northern bean root was jointly modified by high-temperature carbonization treatment and ultrasonic enzymatic hydrolysis treatment.
[0041] In Comparative Examples 3 and 4, only one of chitosan quaternary ammonium salt or modified radix scutellariae was added to the wall material, and it was found that the drug sustained-release performance of the prepared hydrogel wound dressing was significantly reduced. The above results show that after adding chitosan quaternary ammonium salt and modified radix scutellariae to the wall material at the same time, the two act synergistically to greatly improve the sustained-release performance of the material.
[0042] In summary, the present invention obtains modified northern bean root by sequentially subjecting northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying, and then uses the modified northern bean root and chitosan quaternary ammonium salt as components of the wall material, loads the core material inside the wall material, and obtains sustained-release particles; finally, the sustained-release particles are loaded inside the hydrogel to obtain a hydrogel wound dressing with significantly enhanced sustained-release function, and therefore, has good application prospects in wound dressings.
[0043] It should be noted that the above embodiments all belong to the same inventive concept, and the description of each embodiment has its own focus. For matters that are not described in detail in some embodiments, reference may be made to the description in other embodiments.
[0044] The above-mentioned embodiments only express the implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A hydrogel wound dressing with sustained release efficacy, characterized in that: It comprises a hydrogel and slow-release particles loaded inside the hydrogel, wherein the slow-release particles comprise a wall material and a core material loaded inside the wall material; The wall material comprises modified northern bean root and chitosan quaternary ammonium salt, and the modified northern bean root is obtained by sequentially subjecting the northern bean root to high-temperature carbonization, ultrasonic enzymatic hydrolysis and drying.
2. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: The mass ratio of the sustained-release particles to the hydrogel is 1:(5-9); the mass ratio of the core material to the wall material is 1:(7-10); and the mass ratio of the modified northern bean root to the chitosan quaternary ammonium salt is (6-11):(1-3).
3. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: In the preparation process of the modified northern bean root, the high-temperature carbonization step specifically includes: placing the northern bean root in a vacuum environment and carbonizing it at a temperature of 250-450° C. for 2-4 hours.
4. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: In the preparation process of the modified northern bean root, the ultrasonic enzymatic hydrolysis step specifically includes: dissolving the product of the northern bean root after high-temperature carbonization in water, then adding plant hydrolase, and performing enzymatic hydrolysis reaction under ultrasonic conditions; The amount of the plant hydrolase added is 0.1-0.2%; the ultrasonic conditions include: an interval of 20-30s, a power of 50-70W; the enzymatic reaction time is 0.5-1.5h, and the temperature is 25-35°C.
5. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: In the preparation process of the modified northern bean root, the drying step specifically includes: drying the product after the ultrasonic enzymatic hydrolysis at a temperature of 80-100° C. for 1-2 hours.
6. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: The hydrogel comprises polyvinyl alcohol and tannic acid, and the mass ratio of the polyvinyl alcohol to the tannic acid is 1:(0.1-0.3).
7. The hydrogel wound dressing with sustained release efficacy according to claim 1, characterized in that: The core material includes an antibacterial drug, and the antibacterial drug is selected from at least one of levofloxacin, aspirin and indomethacin.
8. A method for preparing a hydrogel wound dressing with sustained release efficacy as claimed in any one of claims 1 to 7, characterized in that: The steps include: Dissolving modified northern bean root and chitosan quaternary ammonium salt in water to obtain a wall material solution; dissolving an antibacterial drug in an organic solvent to obtain a core material solution; The core material solution is added dropwise to the wall material solution, mixed evenly, and then subjected to high pressure homogenization and freeze drying to obtain sustained-release particles; Polyvinyl alcohol and tannic acid are dissolved in water to obtain a mixed solution, the sustained-release particles are added to the mixed solution, and after freezing and thawing, a hydrogel wound dressing is obtained.
9. The preparation method according to claim 8, characterized in that: In the preparation process of the sustained-release granules, the high-pressure homogenization step specifically includes: homogenizing 4 to 6 times at a temperature of 30 to 35° C. and a pressure of 150 to 180 par; The freeze-drying step specifically includes: drying for 4 to 6 hours at a temperature of -15 to 0°C.
10. The preparation method according to claim 8, characterized in that: In the preparation process of the hydrogel wound dressing, the freezing-thawing step specifically includes: first freezing at a temperature of -40 to -10°C for 15 to 30 hours, and then thawing at a temperature of 10 to 20°C for 1 to 10 hours.
Citation Information
Patent Citations
Thiamine nitrate sustained-release microcapsule and preparation method thereof
CN113730376A
Slow-release antibacterial microsphere hydrogel dressing as well as preparation method and application thereof
CN114191604A
Cannabidiol-tannic acid-polyvinyl alcohol hydrogel wound dressing and preparation method thereof
CN114344558A
